Kaplan-Meier survival analysis showed that patients with high expression of NUF2 had a shorter overall survival (OS) and disease-free survival (DFS) compared with low- NUF2 CCA patients (Figure 1I-J). Here, NUF2 is linked to cholangiocarcinoma.